Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration sur le saule

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Neal E. Slatkin - Robert J. Israel

Terms

4Neal E. Slatkin
9Robert J. Israel
3Nancy Stambler
6Lynn R. Webster

Associations

Freq.WeightAssociation
33Neal E. Slatkin - Robert J. Israel
33Nancy Stambler - Robert J. Israel
33Nancy Stambler - Neal E. Slatkin
33Lynn R. Webster - Robert J. Israel
Documents par ordre de pertinence
000066 (2020) Bruce H. Chamberlain [États-Unis] ; Michelle Rhiner [États-Unis] ; Neal E. Slatkin [États-Unis] ; Nancy Stambler [États-Unis] ; Robert J. Israel [États-Unis]Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer.
000406 (2019) Richard L. Rauck [Oman] ; Neal E. Slatkin [États-Unis] ; Nancy Stambler [États-Unis] ; Robert J. Israel [États-Unis]Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.
000922 (2017) Richard Rauck [États-Unis] ; Neal E. Slatkin [États-Unis] ; Nancy Stambler [États-Unis] ; Joseph R. Harper [États-Unis] ; Robert J. Israel [États-Unis]Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
000695 (2018) Lynn R. Webster [États-Unis] ; Robert J. Israel [Oman]Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone.
000696 (2018) Lynn R. Webster [États-Unis] ; Robert J. Israel [Oman]Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain.
000967 (2017) Lynn R. Webster [États-Unis] ; Edward Michna [États-Unis] ; Arif Khan [États-Unis] ; Robert J. Israel [États-Unis] ; Joseph R. Harper [États-Unis]Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
000331 (2020) Lynn R. Webster [États-Unis] ; Martin E. Hale [États-Unis] ; Tadaaki Yamada [États-Unis] ; James E. Wild [États-Unis]A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy.
000409 (2019) Anthony A. Fodor [États-Unis] ; Mark Pimentel [États-Unis] ; William D. Chey [États-Unis] ; Anthony Lembo [États-Unis] ; Pamela L. Golden [États-Unis] ; Robert J. Israel [États-Unis] ; Ian M. Carroll [États-Unis]Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.
000A74 (2017) Herbert L. Dupont [États-Unis] ; Ray A. Wolf [États-Unis] ; Robert J. Israel [États-Unis] ; Mark Pimentel [États-Unis]Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin.
000F20 (2015) Janet Bull [États-Unis] ; Charles V. Wellman [États-Unis] ; Robert J. Israel [États-Unis] ; Andrew C. Barrett [États-Unis] ; Craig Paterson [États-Unis] ; William P. Forbes [États-Unis]Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension.
000F35 (2015) Srinivas R. Nalamachu [États-Unis] ; Joseph Pergolizzi [États-Unis] ; Robert Taylor [États-Unis] ; Neal E. Slatkin [États-Unis] ; Andrew C. Barrett [États-Unis] ; Jing Yu [États-Unis] ; Enoch Bortey [États-Unis] ; Craig Paterson [États-Unis] ; William P. Forbes [États-Unis]Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
000F93 (2015) Lynn R. Webster [États-Unis] ; Darren M. Brenner [États-Unis] ; Andrew C. Barrett [États-Unis] ; Craig Paterson [États-Unis] ; Enoch Bortey [États-Unis] ; William P. Forbes [États-Unis]Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.
001405 (2012) Lynn R. Webster [États-Unis] ; Robert L. Rolleri [États-Unis] ; Glenn C. Pixton [États-Unis] ; Kenneth W. Sommerville [États-Unis]Randomized, double-blind, placebo-controlled and active-controlled study to assess the relative abuse potential of oxycodone HCl-niacin tablets compared with oxycodone alone in nondependent, recreational opioid users.
Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Nov 17 16:35:40 2020. Site generation: Tue Nov 17 16:39:32 2020